Previous Article | Next Article ![]()
Molecular and Cellular Biology, July 2006, p. 5284-5299, Vol. 26, No. 14
0270-7306/06/$08.00+0 doi:10.1128/MCB.00105-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
Ju-Hui T. Ting,1
Noriko N. Yokoyama,1
Alla Bernstein,1
Marc van de Wetering,2 and
Marian L. Waterman1*
Microbiology and Molecular Genetics, University of California, Irvine, Irvine, California 92697,1 Hubrecht Laboratory, Center for Biomedical Genetics, 3458 CT Utrecht, The Netherlands2
Received 17 January 2006/ Returned for modification 17 March 2006/ Accepted 2 May 2006
Alternative promoters within the LEF1 locus produce polypeptides of opposing biological activities. Promoter 1 produces full-length LEF-1 protein, which recruits ß-catenin to Wnt target genes. Promoter 2 produces a truncated form that cannot interact with ß-catenin and instead suppresses Wnt regulation of target genes. Here we show that promoter 1 is aberrantly activated in colon cancers because it is a direct target of the Wnt pathway. T-cell factor (TCF)-ß-catenin complexes bind to Wnt response elements in exon 1 and dynamically regulate chromatin acetylation and promoter 1 activity. Promoter 2 is delimited to the intron 2/exon 3 boundary and, like promoter 1, is also directly regulated by TCF-ß-catenin complexes. Promoter 2 is nevertheless silent in colon cancer because an upstream repressor selectively targets the basal promoter leading to destabilized TCF-ß-catenin binding. We conclude that the biological outcome of aberrant LEF1 activation in colon cancer is directed by differential promoter activation and repression.
Present address: Norris Cancer Center, University of Southern California, Los Angeles, CA 90089.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»